1) Actinobacillus pleuropneumoniae(App) ZY strain
猪胸膜肺炎放线杆菌ZY株
2) Actinobacillus pleuropneumoniae
猪胸膜肺炎放线杆菌
1.
Prokaryotic expression of Actinobacillus pleuropneumoniae out membrane lipoprotein gene;
猪胸膜肺炎放线杆菌外膜脂蛋白基因的原核表达
2.
Prokaryotic expression of capsular polysaccharide genes of Actinobacillus pleuropneumoniae and cytotoxicity assay of expressed products to porcine neutrophil;
猪胸膜肺炎放线杆菌荚膜多糖基因的原核表达及其产物的细胞毒性
3.
Detection of Actinobacillus pleuropneumoniae by PCR;
用PCR检测猪胸膜肺炎放线杆菌
3) Actinobacillus pleuropeumoniae
猪胸膜肺炎放线杆菌
1.
Cross Immunoprotection of Actinobacillus pleuropeumoniae Serotypes 1 and 5;
猪胸膜肺炎放线杆菌血清1和5型交叉免疫保护研究
2.
A pair of primers from the 5′ and 3′ termini of outer membrane lipoprotein(oml) genes of Actinobacillus pleuropeumoniae(App) were selected to be the basis for delvelopment of a specific PCR assay.
根据G enB ank中猪胸膜肺炎放线杆菌(A ctinobacillus p leurop eum on iae,A pp)外膜蛋白(om l)基因序列,设计合成1对特异性引物,进行PCR检测。
5) Actinobacillus pleuropneumoniae
胸膜肺炎放线杆菌
1.
Development of Genotyping System for Actinobacillus pleuropneumoniae and Its Clinical Application;
胸膜肺炎放线杆菌基因分型方法的建立及其临床应用
2.
Establishment of Indirect ELISA for Porcine Actinobacillus pleuropneumoniae;
猪胸膜肺炎放线杆菌间接ELISA检测方法的建立
3.
Expression and analysis of apxIA gene from Actinobacillus pleuropneumoniae in Pichia pastoris;
猪传染性胸膜肺炎放线杆菌apxIA基因在毕赤酵母中的表达与分析
6) Actinobacillus pleuropneumoniae(APP)
胸膜肺炎放线杆菌
1.
A 954 bp fragment corresponded to the main antigen determinant domain of apxIA gene of Actinobacillus pleuropneumoniae(APP)was amplified by polymerase chain reaction (PCR), from serovar I reference strain 259 and was ligated to pMD-18T vector for sequencing.
选取猪传染性胸膜肺炎放线杆菌(APP)apxIA基因序列中的抗原决定簇集中的区域,采用PCR方法从APP血清1型参考株259的基因组DNA中,扩增apxIA基因中约954bp的片段,连接到pMD-18T载体,经测序正确后,以EcoRI和NotI双酶切,亚克隆到原核表达载体pGEX-4T-1中,转化大肠杆菌DH5α,经0。
2.
Induction of tilmicosin resistance in Mycoplasma gallisepticum(MG),Pasteurella multocida(PM) and Actinobacillus pleuropneumoniae(App) were performed by in vitro exposure to stepwise concentration of tilmicosin,and the MICs of macrolides and lincomycin for tilmicosin-resistant mutants were determined.
在测定替米考星对鸡毒支原体、多杀巴氏杆菌和猪胸膜肺炎放线杆菌的最小抑菌浓度基础上,采用药物浓度递增法体外诱导3种病原菌对替米考星的耐药性。
补充资料：肺炎杆菌肺炎
肺炎杆菌肺炎
friedlander baciuus pneumonia
又称“克雷白肺炎”(klebsiella pneumonia），可继发于慢性支气管扩张、流感或结核病，亦可继发于近期使用抗生素之后。原发感染仅偶见婴幼儿，可在乳儿室或病房内因奶瓶、氧化及湿化器等污染而发生交叉感染，甚至造成小流行。此时呕吐、腹泻为首现症状。此病可致广泛肺泡损坏、肺实质坏死、肺脓肿及空洞形成，有大量黏液蛋白渗出物，实变常按照大叶或小叶分布，临床特点：①发病骤起，出现呼吸困难；②年长儿有大量黏稠血性痰，但婴儿少见；③由于气道被黏液梗阻，肺部体征较少或完全缺乏；④病情极为严重，发展迅速，患儿常呈休克状态；⑤X线胸片示肺段或大叶性致密实变阴影，其边缘往往膨胀凸出。可迅速发展到邻近肺段，以上叶后段及下叶前段较多见；⑥常见并发症为肺脓肿，可呈多房性蜂窝状，日后形成纤维性变；其次为脓胸及胸膜肥厚。治疗尚缺乏有效抗菌药物。一般选用庆大或丁胺卡那霉菌。二代或三代头孢菌素如头孢噻肟有效，病死率可降低到50%以下。此病预后严重，病情常迅速进展到呼吸衰竭或中毒性休克，存活病人日后可残留肺部损害。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条